# Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.

> **NCT01963312** · NA · COMPLETED · sponsor: **Fundacion Miguel Servet** · enrollment: 81 (actual)

## Conditions studied

- Transurethral Resection of Prostate
- Artery Embolization
- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **PROCEDURE:** Transarterial Supraselective Embolization of the prostate
- **PROCEDURE:** Transurethral Resection of the prostate

## Key facts

- **NCT ID:** NCT01963312
- **Lead sponsor:** Fundacion Miguel Servet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-04
- **Final completion:** 2018-05
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963312, "Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01963312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*